Del-desiran effectively delivered siRNA to muscle, resulting in approximately 40% mean reduction in DMPK mRNA and amelioration of missplicing Treatment demonstrated improvements in multiple measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results